Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,837.40
-100.10
(-1.26%)
ASX 200
7,575.90
-107.10
(-1.39%)
AUD/USD
0.6535
+0.0012
(+0.18%)
OIL
83.66
+0.09
(+0.11%)
GOLD
2,349.60
+7.10
(+0.30%)
Bitcoin AUD
97,774.36
-805.63
(-0.82%)
Celyad Oncology SA (CLYYF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3580
0.0000
(0.00%)
At close: 09:30AM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
44
0
0
5
Cost of revenue
44
0
0
0
Gross profit
0
0
0
5
Operating expenses
Research development
10,540
18,928
20,773
21,522
Selling general and administrative
7,757
10,337
9,665
9,315
Total operating expenses
8,803
20,263
26,909
26,220
Operating income or loss
-8,803
-20,263
-26,909
-26,215
Interest expense
91
197
255
434
Total other income/expenses net
-
-20,422
523
9,228
Income before tax
-30,554
-40,870
-26,502
-17,204
Income tax expense
65
65
10
0
Income from continuing operations
-30,619
-40,935
-26,512
-17,204
Net income
-30,619
-40,935
-26,512
-17,204
Net income available to common shareholders
-30,619
-40,935
-26,512
-17,204
Basic EPS
-1.36
-1.81
-1.70
-1.23
Diluted EPS
-1.36
-1.81
-1.70
-1.23
Basic average shares
22,558
22,594
15,604
13,942
Diluted average shares
22,558
22,594
15,604
13,942
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.